Galena Biopharma Inc.
Outcome
OIG enforcement action against Galena Biopharma Inc. for false claims, kickbacks, controlled substance. Penalty: $7.5 million.
Details
Galena Biopharma Inc. — OIG Enforcement (2026)
OIG took enforcement action against Galena Biopharma Inc. in 2026 involving false claims, kickbacks, controlled substance violations in the Physician Practices sector.
Penalty: $7.5 million
Violation types: False Claims, Kickbacks, Controlled Substance
Entity type: Physician Practice
Penalty type: Settlement
Source: Galena Biopharma Inc. to Pay More Than $7.55 Million to Resolve Alleged False Claims Related to Opioid Drug
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery. Crucible's referral monitoring tracks patient source patterns and flags arrangements that correlate referral volume with financial relationships, enforcing anti-kickback compliance documentation. Crucible's controlled substance tracking enforces DEA-compliant inventory reconciliation, flags prescribing pattern anomalies, and requires segregation of duties for dispensing and record-keeping.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works